Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 6;82(7):1312–1316. doi: 10.1054/bjoc.1999.1097

Direct activation of oestrogen receptor- α by interleukin-6 in primary cultures of breast cancer epithelial cells

V Speirs 1, M J Kerin 2, D S Walton 1, C J Newton 1, S B Desai 3, S L Atkin 1
PMCID: PMC2374478  PMID: 10755407

Abstract

Interleukin 6 (IL-6) is secreted by breast tumours and shows synergistic activity with 17β-oestradiol (E2), leading to increases in reductive 17β-hydroxysteroid dehydrogenase activity in breast cancer epithelial cells. However, the mechanisms involved are poorly understood. Using short-term epithelial cultures established from primary breast tumours, we have examined whether IL-6 could directly affect transcriptional activity of oestrogen reception α (ERα). Tumour epithelial cultures were established from 15 breast tumours, grown to 70% confluence and transiently transfected with a plasmid reporter containing the vitellogenin oestrogen response element and the luciferase coding sequence (ERE-TK-LUC). Following transfection, cells were incubated with E2, IL-6, the pure anti-oestrogen ZM 182780 or combinations of these substances for 48 h. Luciferase activity was then measured in cell lysates. E2 caused a dose-dependent increase in luciferase expression, causing a maximum threefold stimulation at 100 p M. In the presence of IL-6, transcriptional activity was increased by up to 2.5-fold in ERα+cultures (11/15). In combination with E2, synergistic effects were observed with increases in luciferase activity of up to sixfold over controls. This effect could be blocked by treatment with ZM 182780. Pre-incubation of cells with an antibody directed against the signalling component of IL-6, gp130, was ineffective in blocking the E2 response. This antibody reduced, but did not completely block the effect of IL-6 either alone or in combination with E2, suggesting cross-talk between the two signalling pathways. In conclusion, these results provide evidence for direct transcriptional activation of ERα by IL-6. © 2000 Cancer Research Campaign

Full Text

The Full Text of this article is available as a PDF (69.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asgeirsson K. S., Olafsdóttir K., Jónasson J. G., Ogmundsdóttir H. M. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. Cytokine. 1998 Sep;10(9):720–728. doi: 10.1006/cyto.1998.0349. [DOI] [PubMed] [Google Scholar]
  2. Basolo F., Fiore L., Fontanini G., Conaldi P. G., Calvo S., Falcone V., Toniolo A. Expression of and response to interleukin 6 (IL6) in human mammary tumors. Cancer Res. 1996 Jul 1;56(13):3118–3122. [PubMed] [Google Scholar]
  3. Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2496–2500. doi: 10.1073/pnas.83.8.2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chiu J. J., Sgagias M. K., Cowan K. H. Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res. 1996 Jan;2(1):215–221. [PubMed] [Google Scholar]
  5. Cowley S. M., Hoare S., Mosselman S., Parker M. G. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem. 1997 Aug 8;272(32):19858–19862. doi: 10.1074/jbc.272.32.19858. [DOI] [PubMed] [Google Scholar]
  6. Crichton M. B., Nichols J. E., Zhao Y., Bulun S. E., Simpson E. R. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Cell Endocrinol. 1996 Apr 19;118(1-2):215–220. doi: 10.1016/0303-7207(96)03761-6. [DOI] [PubMed] [Google Scholar]
  7. Dickson R. B., McManaway M. E., Lippman M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science. 1986 Jun 20;232(4757):1540–1543. doi: 10.1126/science.3715461. [DOI] [PubMed] [Google Scholar]
  8. Douglas A. M., Goss G. A., Sutherland R. L., Hilton D. J., Berndt M. C., Nicola N. A., Begley C. G. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene. 1997 Feb 13;14(6):661–669. doi: 10.1038/sj.onc.1200882. [DOI] [PubMed] [Google Scholar]
  9. Duncan L. J., Coldham N. G., Reed M. J. The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Mol Biol. 1994 May;49(1):63–68. doi: 10.1016/0960-0760(94)90301-8. [DOI] [PubMed] [Google Scholar]
  10. Fontanini G., Campani D., Roncella M., Cecchetti D., Calvo S., Toniolo A., Basolo F. Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma. Br J Cancer. 1999 May;80(3-4):579–584. doi: 10.1038/sj.bjc.6690394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Green A. R., Green V. L., White M. C., Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer. 1997 Sep 17;72(6):937–941. doi: 10.1002/(sici)1097-0215(19970917)72:6<937::aid-ijc3>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  12. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. doi: 10.1038/320134a0. [DOI] [PubMed] [Google Scholar]
  13. Greene G. L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986 Mar 7;231(4742):1150–1154. doi: 10.1126/science.3753802. [DOI] [PubMed] [Google Scholar]
  14. Hobisch A., Eder I. E., Putz T., Horninger W., Bartsch G., Klocker H., Culig Z. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res. 1998 Oct 15;58(20):4640–4645. [PubMed] [Google Scholar]
  15. Ignar-Trowbridge D. M., Pimentel M., Parker M. G., McLachlan J. A., Korach K. S. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 1996 May;137(5):1735–1744. doi: 10.1210/endo.137.5.8612509. [DOI] [PubMed] [Google Scholar]
  16. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992 Oct 23;258(5082):593–597. doi: 10.1126/science.1411569. [DOI] [PubMed] [Google Scholar]
  17. Lee A. V., Weng C. N., Jackson J. G., Yee D. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol. 1997 Jan;152(1):39–47. doi: 10.1677/joe.0.1520039. [DOI] [PubMed] [Google Scholar]
  18. Mackiewicz A., Wiznerowicz M., Roeb E., Karczewska A., Nowak J., Heinrich P. C., Rose-John S. Soluble interleukin 6 receptor is biologically active in vivo. Cytokine. 1995 Feb;7(2):142–149. doi: 10.1006/cyto.1995.1019. [DOI] [PubMed] [Google Scholar]
  19. Meyer T., Koop R., von Angerer E., Schönenberger H., Holler E. A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J Cancer Res Clin Oncol. 1994;120(6):359–364. doi: 10.1007/BF01247461. [DOI] [PubMed] [Google Scholar]
  20. Mosselman S., Polman J., Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996 Aug 19;392(1):49–53. doi: 10.1016/0014-5793(96)00782-x. [DOI] [PubMed] [Google Scholar]
  21. Newton C. J., Buric R., Trapp T., Brockmeier S., Pagotto U., Stalla G. K. The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem Mol Biol. 1994 Apr;48(5-6):481–486. doi: 10.1016/0960-0760(94)90197-x. [DOI] [PubMed] [Google Scholar]
  22. Newton C. J., Trapp T., Pagotto U., Renner U., Buric R., Stalla G. K. The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen. J Mol Endocrinol. 1994 Jun;12(3):303–312. doi: 10.1677/jme.0.0120303. [DOI] [PubMed] [Google Scholar]
  23. Novick D., Shulman L. M., Chen L., Revel M. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine. 1992 Jan;4(1):6–11. doi: 10.1016/1043-4666(92)90029-q. [DOI] [PubMed] [Google Scholar]
  24. Pace P., Taylor J., Suntharalingam S., Coombes R. C., Ali S. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem. 1997 Oct 10;272(41):25832–25838. doi: 10.1074/jbc.272.41.25832. [DOI] [PubMed] [Google Scholar]
  25. Reed M. J., Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev. 1997 Oct;18(5):701–715. doi: 10.1210/edrv.18.5.0314. [DOI] [PubMed] [Google Scholar]
  26. Speirs V., Adams E. F., Rafferty B., White M. C. Interactive effects of interleukin-6, 17 beta-estradiol and progesterone on growth and 17 beta-hydroxysteroid dehydrogenase activity in human breast carcinoma cells. J Steroid Biochem Mol Biol. 1993 Jul;46(1):11–15. doi: 10.1016/0960-0760(93)90203-9. [DOI] [PubMed] [Google Scholar]
  27. Speirs V., Green A. R., Walton D. S., Kerin M. J., Fox J. N., Carleton P. J., Desai S. B., Atkin S. L. Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer. 1998 Dec;78(11):1421–1429. doi: 10.1038/bjc.1998.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Speirs V., Green A. R., White M. C. A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples. Int J Cancer. 1996 May 16;66(4):551–556. doi: 10.1002/(SICI)1097-0215(19960516)66:4<551::AID-IJC21>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  29. Speirs V., Walton D. S., Hall M. C., Atkin S. L. In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6. Br J Cancer. 1999 Oct;81(4):690–695. doi: 10.1038/sj.bjc.6690749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Speirs V., White M. C., Green A. R. Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue. In Vitro Cell Dev Biol Anim. 1996 Feb;32(2):72–74. doi: 10.1007/BF02723036. [DOI] [PubMed] [Google Scholar]
  31. Takeda T., Kurachi H., Yamamoto T., Nishio Y., Nakatsuji Y., Morishige K. i., Miyake A., Murata Y. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol. 1998 Nov;159(2):323–330. doi: 10.1677/joe.0.1590323. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES